curacle co.,ltd.

₩7,510As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:365270Healthcare
Country South Korea
PE (Fwd) •••
TSR 5Y CAGR (23.90%)
Div yield —
ROE (22.56%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 2.04
PE TTM —
TSR TTM 37.55%
Mkt cap ₩166.4B
ROIC (10.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩9,718
29.40%
(53.82%)
Hold 0|8|4|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
155.35
158.07
160.56
164.52
9.59%
0.97%
7.06%
7.18%
Revenue₩B
9.508
9.241
9.746
10.15
18.43%
12.07%
13.98%
12.43%
Peers (US$122.7M)
Cap (US$)
PE
124.0M
—
121.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.339
0.685
0.539
EBIT/Intx
1.239
2.082
1.826
Own earn%
73.34
(2.06)
6.71
Sh yield%
27.28
27.84
27.36
Owners
Insiders/Inst%
9.54
65.84
Short interest%
0.61
SBC / revenue%
0.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
15–21
$1 testx
—
Incr. ROIC%
5